BSE filing, NSE: PARASHLTH. Summary written from the filing by ALFA Finder's alert engine.
Paras Healthcare Ltd: key numbers
- Share price
- ₹739.30
- Market cap
- ₹7,999 Cr
- Revenue (annual)
- ₹1,606 Cr
- Net profit (annual)
- ₹43.83 Cr
- Promoter holding
- 63.95%
- FII holding
- 11.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Paras Healthcare Ltd
All →Paras Healthcare Capital Structure Change
360 ONE funds disclose conversion of 78.82 lakh pre-IPO unlisted Paras Healthcare shares into listed shares at 7.28% stake. No new shares were acquired; the holding remained unchanged post-listing.
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Paras Healthcare Other Announcement
Paras Healthcare files its quarterly shareholding pattern as of 28 October 2026. Promoter group holds about 63.95 percent of the company.
Other board meeting date announcements
All →National General Industries Board Meeting Date
National General Industries will hold a board meeting on November 10, 2026 to consider unaudited quarterly results. Trading window stays closed until November 16, 2026.
Vision Cinemas Board Meeting Date
Vision Cinemas Limited has intimated a board meeting on 10 November 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. The trading window is closed from 1 October 2026 until 48 hours after results declaration.
Gujarat Narmada Valley Fertilizers & Chemicals Board Meeting Date
GNFC clarified its November 2, 2026 board meeting date was wrongly printed as 2025 in earlier intimations. Only the date is corrected; other information is unchanged.
VCU Data Management Board Meeting Date
VCU Data Management scheduled a board meeting for 6 November 2026. It will consider unaudited Q2 and half-year results for the period ended September 2026.
Eiko Lifesciences Board Meeting Date
Eiko Lifesciences has scheduled a board meeting for November 5, 2026, to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
EFORU Entertainment Board Meeting Date
Eforu Entertainment announced a board meeting on 05 November 2026 to consider unaudited quarterly and half-year results. Results remain unreported until the meeting is held.